![]() The agreement between the results of the two tests were represented by a Kappa value of 0.111 for the BSID III assessed as “at risk” (p = 0.014), and 0.423 for the BSID III assessed as “handicapped” (p < 0.000). The Denver II had a specificity greater than 90%.for both BSID III composite cutoff values. 8% and 44.0% for a 14 BSID III composite score cutoff of <85 (“at risk”), and <70 (“handicapped”) respectively. The sensitivity of the Denver II in identifying developmental delay was. The results of infants that had both a Denver II and a BSID III were assessed. The study population consisted of both normal and high 10 risk neonates born between 1 July 2013 and 31 December 2015. This is a retrospective descriptive study. The Bayley Scales of Infant and Toddler Development III (BSID III) is used as a gold standard test, to determine the level of agreement between the two tests. ![]() ![]() This article aims at assessing the accuracy of the Denver II in identifying developmental delay 6 in high risk newborns. The Denver Developmental Screening Test II (Denver II) is used to assess the development of high risk newborns at a tertiary hospital in Johannesburg. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |